Serine/threonine-protein kinase BGLF4 · SINGLE PROTEIN · Epstein-Barr virus (strain GD1) (HHV-4) (Human herpesvirus 4)
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Serine/threonine-protein kinase BGLF4 shows approved-linked disease relevance led by cytomegalovirus infection. 1 more disease program remain visible in the same review block. 1 linked drug keeps the current disease frame grounded. Protein identity stays anchored to UniProt P0C731. Start with cytomegalovirus infection, then reuse UniProt P0C731 as the stable protein anchor across project notes and exports.
Start with cytomegalovirus infection, then reuse UniProt P0C731 as the stable protein anchor across project notes and exports.
Serine/threonine-protein kinase BGLF4 shows approved-linked disease relevance led by cytomegalovirus infection. 1 more disease program remain visible in the same review block. 1 linked drug remains visible in the same block.
Start review with cytomegalovirus infection because it currently carries approved-linked support. Linked drugs include MARIBAVIR. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
Disease source · ChEMBL drug mechanism + indication proxySerine/threonine-protein kinase BGLF4
Review this target as Serine/threonine-protein kinase BGLF4, mapped to UniProt P0C731. Sequence length is 429 aa.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Serine/threonine-protein kinase BGLF4 as ChEMBL target CHEMBL3833483, mapped to UniProt P0C731. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Serine/threonine-protein kinase BGLF4 is the right protein anchor across sources, using UniProt P0C731 as the stable mapping.
Jump to Protein ContextUse this block first when you need to confirm why cytomegalovirus infection is currently framed as approved-linked support. It currently carries 1 linked drug in the same disease frame.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Serine/threonine-protein kinase BGLF4 |
| Target Type | SINGLE PROTEIN |
| Organism | Epstein-Barr virus (strain GD1) (HHV-4) (Human herpesvirus 4) |
| UniProt | P0C731 |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Serine/threonine-protein kinase BGLF4 |
| UniProt Accession | P0C731 |
| Component Type | Protein |
| Sequence Length | 429 aa |
Serine/threonine-protein kinase BGLF4
Review this target as Serine/threonine-protein kinase BGLF4, mapped to UniProt P0C731. Sequence length is 429 aa.
Open Targets-ready disease context using the current target-indication evidence contract.
Serine/threonine-protein kinase BGLF4 shows approved-linked disease relevance led by cytomegalovirus infection. 1 more disease program remain visible in the same review block.
Start review with cytomegalovirus infection because it currently carries approved-linked support. Linked drugs include MARIBAVIR. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.